About this trial
The objective of this clinical trial is to evaluate the safety and efficacy of Versius in Inguinal Hernia repair surgery
Eligibility criteria
Qualifiers
Adult patients 22 years of age and older, deemed eligible for elective minimal invasive inguinal Hernia repair surgery.
Patients providing written informed consent to participate in the study.
Disqualifiers
Patient unwilling to provide informed consent.
Medical contraindication for general anaesthesia or minimally invasive procedure.
Patient participation in an interventional clinical study that could impact primary outcomes results.
Patient who falls into American Society of Anaesthesiologists (ASA) Class IV or above.
Trial design
Treatments tested in this trial
- Versius Surgical System
Treatment groups
Sponsors and collaborators
CMR Surgical Ltd
Lead sponsor
Division of General Oncologic and Minimally Invasive Surgery, Niguarda Hospital Milan
Collaborator